Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.48 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 3/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.45 |
| ▸ | IMPDH2 | P12268 | 2/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30096370 | 1.00 | PPARG (0.48) | PPARGPPARDPPARADNMT1SIRT5 | |
| SCHEMBL29861961 | 1.00 | PPARG (0.48) | PPARGPPARDPPARADNMT1SIRT5 | |
| SCHEMBL30190118 | 0.81 | IMPDH2 (0.54) | PPARGPPARDPPARADNMT1SIRT5 | |
| SCHEMBL30190135 | 0.77 | PPARG (0.45) | PPARGPPARDPPARADNMT1SIRT5 | |
| SCHEMBL30190271 | 0.77 | ALOX5 (0.46) | PPARGAPPALOX5IMPDH2PTGS2 | |
| SCHEMBL31540353 | 0.75 | ALOX15 (0.43) | APPBACE1 | |
| SCHEMBL31540354 | 0.75 | ALOX15 (0.43) | APPBACE1 | |
| Hericenone J SCHEMBL15828327 | 0.74 | IMPDH2 (0.77) | PPARGPPARDPPARADNMT1SIRT5 | |
| Hericenone J SCHEMBL29862379 | 0.74 | IMPDH2 (0.77) | PPARGPPARDPPARADNMT1SIRT5 | |
| SCHEMBL6230269 | 0.73 | PPARG (0.59) | PPARGPPARDPPARADNMT1SIRT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022187973-A1 | DOSING REGIMENS OF PHARMACEUTICAL AND NUTRACEUTICAL MUSHROOM AND CANNABIS COMPOSITIONS AND THEIR USE TO TREAT CNS DISORDERS AND IMPROVE MENTAL HEALTH | ALLIED CORP. (CA) | 2022-09-15 | — | — | WO | disclosed |